Erlanger looks to join Prisma Health: What would the change mean for patients?

July 24, 2026 - 02:38

A potential new partnership between Erlanger Health System and Prisma Health could reshape healthcare delivery in the Chattanooga region. On Wednesday, Erlanger officials confirmed they are in early discussions with Prisma, a large nonprofit health system based in South Carolina, to explore a formal affiliation. The move would bring together Erlanger's regional network with Prisma's extensive resources, which include 18 hospitals and over 2,900 beds across the Carolinas.

For patients, the most immediate change would likely be expanded access to specialized care. Prisma operates major academic medical centers and research programs, which could allow Erlanger patients to consult with top specialists without traveling far. The partnership might also streamline referrals for complex procedures, such as advanced cardiac or cancer treatments, by connecting Erlanger's facilities directly to Prisma's larger system.

However, some local observers worry about potential shifts in control. Erlanger is a public health system, accountable to the community through a board appointed by local officials. A merger or affiliation with an out-of-state entity could raise questions about local decision-making and whether services would remain centered on Chattanooga. Erlanger leaders have emphasized that no final decisions have been made and that any agreement would prioritize keeping care close to home.

Financial stability is another factor. Like many hospitals, Erlanger has faced rising costs and staffing shortages. Joining a larger network like Prisma could provide economies of scale, better negotiating power with insurers, and access to capital for new equipment or facilities. Patients might see more consistent pricing and fewer surprise bills if the systems align their billing practices.

The talks are still in a preliminary phase, with both sides conducting due diligence. A formal announcement could come in the coming months, but officials caution that many details remain unsettled. For now, patients should expect no immediate changes to their care or insurance networks.